021-51111890
购物车（0）
sales@molnova.cn
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2
CAS No. 1647119-61-6
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 ( —— )
产品货号. M30172 CAS No. 1647119-61-6
c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 is a selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07nM and 0.02 nM for hV2R and rV2R, respectively.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 100MG | 获取报价 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
生物学信息
-
产品名称c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 is a selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07nM and 0.02 nM for hV2R and rV2R, respectively.
-
产品描述c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-d-Arg-NEt2 is a selective and short-acting peptidic V2 receptor (V2R) agonist with EC50s of 0.07nM and 0.02 nM for hV2R and rV2R, respectively.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体EC50: 0.07 nM (hV2R), 0.02 nM (rV2R)
-
研究领域——
-
适应症——
化学信息
-
CAS Number1647119-61-6
-
分子量946.58
-
分子式C42H60ClN11O8S2
-
纯度>98% (HPLC)
-
溶解度——
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
Wi?niewski K, et al. Discovery of Potent, Selective, and Short-Acting Peptidic V2 Receptor Agonists. J Med Chem. 2019 May 23;62(10):4991-5005.
产品手册
关联产品
-
Clozic
Clozic 表现出可逆的抗增殖作用，可用于作为潜在抗关节炎药物的研究。
-
PACAP (1-27), human,...
PACAP (1-27), human, ovine, rat TFA (PACAP 1-27 TFA) is an N-terminal fragment of pacap-38 and an effective PACAP receptor antagonist. The IC50s for rat PAC1, rat VPAC1 and human VPAC2 are 3nm, 2nm and 5nm respectively.
-
ADX-102
ADX-102（Reproxalap，NS-2）是一种新型小分子免疫调节剂，可共价结合醛类，包括丙二醛和 4-羟基壬烯醛。
